Clinical Trial Update: Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Open-label, single-arm Phase 3 trial of BI 695502 in previously untreated metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BI 695502 (BI 695502)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Colorectal Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2019-11-21